Showing results (281-290 of 299) with videos related to
Sort By:
Pageof 30
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.Blood|May 15, 2007
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropeniaDaniel C Link, Ghada Kunter, Yumi Kasai, et al.Nature Communications|December 13, 2019
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.Nature Communications|July 30, 2020
Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.Nature Communications|February 2, 2020
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolismMarta Pradas-Juni, Nils R Hansmeier, Jenny C Link, et al.JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.Pageof 30